Nitrogenated heterocyclic compound

Disclosed is a nitrogenated heterocyclic compound represented by general formula (1).  The compound or a salt thereof exhibits a potent antagonistic activity on an EP1 receptor when administered to a human body or an animal.  Therefore, the compound or a salt thereof is useful, for example, as an ac...

Full description

Saved in:
Bibliographic Details
Main Authors ATOBE, MASAKAZU, NAGANUMA, KENJI, MORIMOTO,  AKIFUMI, KOBAYASHI, TERUKI
Format Patent
LanguageEnglish
Published 13.10.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is a nitrogenated heterocyclic compound represented by general formula (1).  The compound or a salt thereof exhibits a potent antagonistic activity on an EP1 receptor when administered to a human body or an animal.  Therefore, the compound or a salt thereof is useful, for example, as an active ingredient for a pharmaceutical agent for preventing and/or treating overactive bladder.  The compound or a salt thereof is also useful as an active ingredient for a pharmaceutical agent for preventing and/or treating a symptom such as frequent urination, urgency of urination or urinary incontinence.
Bibliography:Application Number: AU20090272033